The German conglomerate announced a licensing agreement with Puhe BioPharma for a PRMT5 inhibitor used in a variety of cancers. Financial details of the deal were not disclosed.
Bayer is a Germany-based holding company that owns and operates businesses in areas such as pharmaceuticals, consumer health and crop protection across the globe.